MedTrace Logo

Cytosponge™ Feasibility Study in Tanzania

NCT04090554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2021-08-25

No results posted yet for this study

Summary

A Tanzanian pilot study to test the feasibility of using the Cytosponge™ device - a less-invasive endoscopy alternative - for research on esophageal squamous cell carcinoma in African settings.

Conditions

  • Esophageal Diseases
  • Esophagus SCC

Interventions

DEVICE

Cytosponge™

The device consists of a spherical mesh enclosed in a gelatine capsule and attached to a string. The capsule is swallowed and allowed to reach the stomach . In the stomach the capsule is left for up to 5 minutes where it dissolves allowing the sponge to expand to its full size. It is then withdrawn using the suture, and as it does so collects cells from the lining of the oesophagus.

Sponsors & Collaborators

  • Kilimanjaro Clinical Research Institute

    collaborator OTHER

  • University of Cambridge

    collaborator OTHER

  • International Agency for Research on Cancer

    lead OTHER

Principal Investigators

  • Valerie A McCormack, PhD · International Agency for Research on Cancer

  • Venance Maro, MD · Kilimanjaro Clinical Research Institute

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-24
Primary Completion
2019-12-20
Completion
2020-12-30

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090554 on ClinicalTrials.gov